Randomised assessor-masked trial evaluating topical manuka honey (Optimel) in treatment of meibomian gland dysfunction.

CONCLUSIONS: Optimel 16% manuka honey eye-drops showed significant improvement in symptoms and objective signs in meibomian gland dysfunction and are an effective alternative treatment for meibomian gland dysfunction. TRIAL REGISTRATION NUMBER: NCT04457648. PMID: 33419788 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33419788?dopt=Abstract

Source: The British Journal of Ophthalmology - January 8, 2021 Category: Opthalmology Authors: Li AL, Li SL, Kam KW, Young AL Tags: Br J Ophthalmol Source Type: research